BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li H, Huang MH, Jiang JD, Peng ZG. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy. World J Gastroenterol 2018; 24(47): 5297-5311 [PMID: 30598575 DOI: 10.3748/wjg.v24.i47.5297] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Marsella M, Ricchi P. Thalassemia and hepatocellular carcinoma: links and risks. J Blood Med 2019;10:323-34. [PMID: 31572038 DOI: 10.2147/JBM.S186362] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
2 Sharma G, Sharma AR, Bhattacharya M, Lee SS, Chakraborty C. CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases. Mol Ther 2021;29:571-86. [PMID: 33238136 DOI: 10.1016/j.ymthe.2020.09.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
3 Sekulic S, Mijailovic Z, Petrovic D, Lukic R, Jovanovic M, Jovanovic I. HCV Infection and Chronic Renal Disease. Serbian Journal of Experimental and Clinical Research 2021;0:000010247820210010. [DOI: 10.2478/sjecr-2021-0010] [Reference Citation Analysis]
4 Cavicchioli F, Cesarotti IM, Fangman M, Lua J, Hautamaki R, Doré S. Carbon Monoxide Therapy Using Hybrid Carbon Monoxide-Releasing/Nrf2-Inducing Molecules through a Neuroprotective Lens. Chemistry 2021;3:800-17. [DOI: 10.3390/chemistry3030057] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Khayat MT, Omar AM, Elfaky MA, Muhammad YA, Felemban EA, El-say KM, El-araby ME, Xie J. Reexamining Povarov Reaction’s Scope and Limitation in the Generation of HCV-NS4A Peptidomimetics. Heteroatom Chemistry 2022;2022:1-12. [DOI: 10.1155/2022/8181543] [Reference Citation Analysis]
6 Abrahamovych M, Abrahamovych O, Fayura O, Tolopko S. Relation between redox homeostasis blood parameters in cirrhotic patients and endothelial dysfunction development. Minerva Gastroenterol Dietol 2020;66:98-105. [PMID: 32218418 DOI: 10.23736/S1121-421X.20.02654-9] [Reference Citation Analysis]
7 Liu X, Chai B, Wang X, Wu Z, Zou H, Liu Y, Zheng S, Qian G, Ma Z, Lu J. Environmentally Persistent Free Radical Promotes Lung Cancer Progression by Regulating the Expression Profile of miRNAs. Cancer Biother Radiopharm 2022. [PMID: 35594306 DOI: 10.1089/cbr.2021.0378] [Reference Citation Analysis]
8 Ramírez-Zamudio LC, Castillo-Barradas M. Seroprevalence of the hepatitis C virus in healthcare personnel of the IMSS. Rev Gastroenterol Mex (Engl Ed) 2020:S0375-0906(20)30092-6. [PMID: 32919793 DOI: 10.1016/j.rgmx.2020.06.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Hammerstad SS, Blackard JT, Lombardi A, Owen RP, Concepcion E, Yi Z, Zhang W, Tomer Y. Hepatitis C Virus Infection of Human Thyrocytes: Metabolic, Hormonal, and Immunological Implications. J Clin Endocrinol Metab 2020;105:dgz241. [PMID: 31784757 DOI: 10.1210/clinem/dgz241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Fazeli P, Saeidnia M, Erfani M, Kalani M. An overview of the biological and multifunctional roles of IL-38 in different infectious diseases and COVID-19. Immunol Res 2022. [PMID: 35260945 DOI: 10.1007/s12026-022-09275-y] [Reference Citation Analysis]
11 Kostadinova L, Shive CL, Anthony DD. Elevated Autotaxin and LPA Levels During Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation. Cancers (Basel) 2019;11:E1867. [PMID: 31769428 DOI: 10.3390/cancers11121867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
12 Leone V, Ali A, Weber A, Tschaharganeh DF, Heikenwalder M. Liver Inflammation and Hepatobiliary Cancers. Trends Cancer 2021;7:606-23. [PMID: 33674229 DOI: 10.1016/j.trecan.2021.01.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wan Z, Li H, Wu X, Zhao H, Wang R, Li M, Liu J, Liu Q, Wang R, Li X. Hepatoprotective effect of gentiopicroside in combination with leflunomide and/or methotrexate in arthritic rats. Life Sci 2021;265:118689. [PMID: 33130083 DOI: 10.1016/j.lfs.2020.118689] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Ramírez-Zamudio LC, Castillo-Barradas M. Seroprevalence of the hepatitis C virus in healthcare personnel of the IMSS. Rev Gastroenterol Mex (Engl Ed) 2021:S2255-534X(21)00078-5. [PMID: 34393076 DOI: 10.1016/j.rgmxen.2021.07.005] [Reference Citation Analysis]
15 Wen D, Du X, Dong JZ, Ma CS. Hepatitis C virus infection and risk of coronary artery disease: A meta-analysis. Eur J Intern Med 2019;63:69-73. [PMID: 31006509 DOI: 10.1016/j.ejim.2019.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Qian S, Golubnitschaja O, Zhan X. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA J 2019;10:365-81. [PMID: 31832112 DOI: 10.1007/s13167-019-00194-x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 19.0] [Reference Citation Analysis]
17 Mendlowitz A, Bremner KE, Walker JD, Wong WWL, Feld JJ, Sander B, Jones L, Isaranuwatchai W, Krahn M. Health care costs associated with hepatitis C virus infection in First Nations populations in Ontario: a retrospective matched cohort study. CMAJ Open 2021;9:E897-906. [PMID: 34584004 DOI: 10.9778/cmajo.20200247] [Reference Citation Analysis]
18 Galli A, Munnia A, Cellai F, Tarocchi M, Ceni E, van Schooten FJ, Godschalk R, Giese RW, Peluso M. Ligation-Mediated Polymerase Chain Reaction Detection of 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine and 5-Hydroxycytosine at the Codon 176 of the p53 Gene of Hepatitis C-Associated Hepatocellular Carcinoma Patients. Int J Mol Sci 2020;21:E6753. [PMID: 32942546 DOI: 10.3390/ijms21186753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Husa P, Snopkova S, Zavrelova J, Zlamal F, Svacinka R, Husa P. Circulating microparticles in patients with chronic hepatitis C and changes during direct-acting antiviral therapy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021;165:146-51. [PMID: 33928944 DOI: 10.5507/bp.2021.023] [Reference Citation Analysis]
20 Su X, Zhao X, Deng JL, Li SN, Du X, Dong JZ, Ma CS. Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta-analysis. J Viral Hepat 2021;28:664-71. [PMID: 33452699 DOI: 10.1111/jvh.13469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Phi van V, Reiner CS, Klarhoefer M, Ciritsis A, Eberhardt C, Wurnig MC, Rossi C. Diffusion tensor imaging of the abdominal organs: Influence of oriented intravoxel flow compartments. NMR in Biomedicine 2019;32. [DOI: 10.1002/nbm.4159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Grewal T, Buechler C. Emerging Insights on the Diverse Roles of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Chronic Liver Diseases: Cholesterol Metabolism and Beyond. IJMS 2022;23:1070. [DOI: 10.3390/ijms23031070] [Reference Citation Analysis]
23 Medrano LM, Berenguer J, Salgüero S, González-García J, Díez C, Hontañón V, Garcia-Broncano P, Ibañez-Samaniego L, Bellón JM, Jiménez-Sousa MA, Resino S. Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study. Front Med (Lausanne) 2021;8:615342. [PMID: 33598470 DOI: 10.3389/fmed.2021.615342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Lv T, Cao W, Li T. HIV-Related Immune Activation and Inflammation: Current Understanding and Strategies. J Immunol Res 2021;2021:7316456. [PMID: 34631899 DOI: 10.1155/2021/7316456] [Reference Citation Analysis]
25 Peschel G, Grimm J, Gülow K, Müller M, Buechler C, Weigand K. Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver Injury. Diagnostics (Basel) 2020;10:E974. [PMID: 33228201 DOI: 10.3390/diagnostics10110974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Li H, Liu NN, Peng ZG. Effect of bicyclol on blood biomarkers of NAFLD: a systematic review and meta-analysis. BMJ Open 2020;10:e039700. [PMID: 33277283 DOI: 10.1136/bmjopen-2020-039700] [Reference Citation Analysis]
27 Kaur N, Goyal G, Garg R, Tapasvi C, Chawla S, Kaur R. Potential role of noninvasive biomarkers during liver fibrosis. World J Hepatol 2021; 13(12): 1919-1935 [DOI: 10.4254/wjh.v13.i12.1919] [Reference Citation Analysis]
28 Venuto CS, Cramer YS, Rosenkranz SL, Sulkowski M, Wyles DL, Cohen DE, Schmidt J, Alston-Smith BL, Morse GD. Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s. Br J Clin Pharmacol 2020;86:132-42. [PMID: 31656054 DOI: 10.1111/bcp.14148] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Ji Q, Chu X, Zhou Y, Liu X, Zhao W, Ye W. Safety and efficacy of grazoprevir/elbasvir in the treatment of acute hepatitis C in hemodialysis patients. J Med Virol 2021. [PMID: 34599755 DOI: 10.1002/jmv.27374] [Reference Citation Analysis]
30 Donnally CJ 3rd, Patel PD, Canseco JA, Shenoy K, Divi SN, Goz V, Arain AR, Vaccaro AR. Hepatitis C Virus Infection as a Predictor of Complications and Increased Costs Following Primary Lumbar Fusion Surgery. Spine (Phila Pa 1976) 2020;45:E1020-5. [PMID: 32706565 DOI: 10.1097/BRS.0000000000003481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Mendlowitz A, Bremner KE, Walker JD, Wong WWL, Feld JJ, Sander B, Jones L, Isaranuwatchai W, Krahn M. Hepatitis C virus infection in First Nations populations in Ontario from 2006 to 2014: a population-based retrospective cohort analysis. CMAJ Open 2021;9:E886-96. [PMID: 34584007 DOI: 10.9778/cmajo.20200164] [Reference Citation Analysis]
32 Almaeen AH, Alduraywish AA, Mobasher MA, Almadhi OIM, Nafeh HM, El-Metwally TH. Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients. Arch Med Sci 2021;17:368-75. [PMID: 33747272 DOI: 10.5114/aoms.2019.91451] [Reference Citation Analysis]
33 Guo Y, Bao L, Xu Y, Li F, Lv Q, Fan F, Qin C. The Ablation of Envelope Protein Glycosylation Enhances the Neurovirulence of ZIKV and Cell Apoptosis in Newborn Mice. J Immunol Res 2021;2021:5317662. [PMID: 34327243 DOI: 10.1155/2021/5317662] [Reference Citation Analysis]
34 Durand CM, Zhang W, Brown DM, Yu S, Desai N, Redd AD, Bagnasco SM, Naqvi FF, Seaman S, Doby BL, Ostrander D, Bowring MG, Eby Y, Fernandez RE, Friedman-Moraco R, Turgeon N, Stock P, Chin-Hong P, Mehta S, Stosor V, Small CB, Gupta G, Mehta SA, Wolfe CR, Husson J, Gilbert A, Cooper M, Adebiyi O, Agarwal A, Muller E, Quinn TC, Odim J, Huprikar S, Florman S, Massie AB, Tobian AAR, Segev DL; HOPE in Action Investigators. A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. Am J Transplant 2021;21:1754-64. [PMID: 32701209 DOI: 10.1111/ajt.16205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]